期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

艰难梭菌感染实验室检测技术及其研究进展 被引量：4

下载PDF
导出
摘要 艰难梭菌（CD）是一种专性厌氧的革兰染色阳性芽孢杆菌,它广泛分布于自然环境、动物和人的粪便中,芽孢抵抗力较强,可在外界环境存活数周至数月。CD本身没有侵袭性,部分产毒细菌通过分泌毒素A、毒素B及二元毒素引起抗菌药物相关性腹泻、结肠炎甚至致死性假膜性肠炎,统称为艰难梭菌感染（CDI）。
作者 龙海燕 杨菁玉 冯萍
机构地区 四川大学华西医院感染性疾病中心
出处 《检验医学与临床》 CAS 2015年第8期1143-1145,1148,共4页 Laboratory Medicine and Clinic
关键词 艰难梭菌 细菌培养 毒素检测 免疫学 分子生物学
分类号 R557.1 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献25

  • 1Surawicz CM, Brandt LJ, Binion DG,et al. Guidelines for di-agnosis ,treatment, and prevention of clostridium difficile in-?ections[J]. Am J Gastroenterol ,2013,108(4) : 478-498.
  • 2Sullivan NM’Pellett S? Wilkins TD. Purification and char-acterization of toxins A and B of clostridium difficile[J].Infect Immun, 1982,35(3) : 1032-1040.
  • 3Lyras D^O^onnor JR, Howarth PM,et al. Toxin B is es-sential for virulence of clostridium difficile [J]. Nature,2009,458(7242).1176-1179.
  • 4Rene P,Frenette CP,Schiller I,et al. Comparison of eightcommercial enzyme immunoassays for the detection ofclostridium difficile from stool samples and effect of straintype[J]. Diagn Microbiol Infect Dis,2012,73(l) :94-96.
  • 5Polage CR>Chin DL,Leslie JL,et al. Outcomes in patientstested for clostridium difficile toxins [J]. Diagn MicrobiolInfect Dis,2012,74(4) :369-373.
  • 6Guerrero DM,Chou C? Jury LA,et al. Clinical and infec-tion control implications of clostridium difficile infectionwith negative enzyme immunoassay for toxin[J]. Clin In-fect Dis,2011,53(3):287-290.
  • 7Humphriesa RM, Uslanb DZ? Rubinb Z. Performance ofclostridium difficile toxin enzyme immunoassay and nu-cleic acid amplification tests stratified by patient diseaseseverity[J]. J Clin Microbiol,2013 *51(3) *869-873.
  • 8Longtin Y,Trottier S,Brochu G,et al. Impact of the typeof diagnostic assay on clostridium difficile infection andcomplication rates in a mandatory reporting program [J].Clin Infect Dis,2013,56(1) :67-73.
  • 9Foster NF,Riley TV. Improved recovery of clostridiumdifficile spores with the incorporation of synthetic tauro-cholate in cycloserine-cefoxitin-fructose agar(CCFA) [J].Pathology,2012,44(4) :354-356.
  • 10Crobach MJ,Dekkers OM,Wilcox MH,et al. European soci-ety of clinical microbiology and infectious diseases (ESC-MID) : data review and recommendations for diagnosing clos-tridium difficile-infection ( CDI) [J]. Clin Microbiol Infect,2009,15(12):1053-1066.

同被引文献55

  • 1David L. McCollum,J. Martin Rodriguez.Detection, Treatment, and Prevention of Clostridium difficile Infection[J].Clinical Gastroenterology and Hepatology.2012(6)
  • 2Andrea Lo Vecchio,George M. Zacur.Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options[J].Current Opinion in Gastroenterology.2012(1)
  • 3Cohen SH,Gerding DN, Johnson S, et al. Clinical practice guide-lines for Clostridium difficile infection in adults; 2010 update bythe society for healthcare epidemiology of America (SHEA) andthe infectious diseases society of America (IDSA)[J]. Infect Con-trol Hosp Epidemiol. 2010,31(5) :431-455.
  • 4Ananthakrishnan AN. Clostridium difficile infection: epidemiolo-gy, risk factors and management [J]. Nat Rev GastroenterolHepatol,2011,8(1) :17-26.
  • 5Gasperino J’Garala M, Cohen HW, et al. Investigation of criticalcare unit utilization and mortality in patients infected with Clos-tridium difficile[J]. J Crit Care,2010,25(2) :282-286.
  • 6Shetty N, Wren MW, Coen PG. The role of glutamate dehydro-genase for the detection of Clostridium difficile in faecal samples:a meta-analysis[J]. J Hosp Infect,2011,77(1) : 1-6.
  • 7Longtin Y,Trottier S,Brochu G,et al. Impact of the type of diag-nostic assay on Clostridium difficile infection and complicationrates in a mandatory reporting program[J]. Clin Infect Dis,2013,56(1)=67-73.
  • 8Deak E,Miller SA, Humphries RM. Comparison of Illumigene,Simplexa, and AmpliVue Clostridium difficile molecular assaysfor diagnosis of C. difficile infection[J]. J Clin Microbiol,2014,52(3):960-963.
  • 9Barbut F, Surgers L, Eckert C, et al. Does a rapid diagnosis ofClostridium difficile infection impact on quality of patient manage-ment? [J], Clin Microbiol Infect,2014,20(2) : 136-144.
  • 10Garg S, Mirza YR, Girotra M, et al. Epidemiology of Clostridium d/ffwi/e-associated disease (CDAD): a shift from hospital-ac- quired infection to longterm care facility-based infection [ J ]. Dig Dis Sci,2013,58(12) :3407 -3412.

引证文献4

二级引证文献5

检验医学与临床
2015年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部